Erik Springer

31 papers receiving 1.0k citations

Peers

Erik Springer
Comparison fields: 5 of 77
  • Microbiology 25
  • Oncology 326
  • Endocrinology, Diabetes and Metabolism 147
  • Orthopedics and Sports Medicine 48
  • Cell Biology 98
Replace Melek Ergin with:
Melek Ergin Türkiye
Nicole Massoll United States
E Bucciarelli Italy
P Resnitzky Israel
A Premkumar United States
Katsuhiko Hasumi Japan
Yasuhide Kitagawa Japan
E. Mackay United Kingdom
Fujitsugu Matsubara Japan
Françoise Picard France
Erik Springer relative to Melek Ergin Türkiye Melek Ergin's profile →
Citations per field
00.5×8.3×
Melek Ergin · 1×
Citations per year

Countries citing papers authored by Erik Springer

Since Specialization
Citations

This map shows the geographic impact of Erik Springer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Springer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Springer more than expected).

Fields of papers citing papers by Erik Springer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Springer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Springer. The network helps show where Erik Springer may publish in the future.

Co-authors

The 25 scholars most cited alongside Erik Springer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erik Springer Line = papers co-authored together Erik Springer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.
1999319
2 2007158
3 200195
4 201059
5 201958
6 200653
7 201736
8 201027
9 201824
10 200622
11 201421
12 200620
13 201019
14 201618
15 201516
16 201815
17 200614
18 200714
19 201913
20 201011

About Erik Springer

Erik Springer is a scholar working on Oncology, Molecular Biology, Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (7 papers), Hepatitis B Virus Studies (2 papers), Microtubule and mitosis dynamics (2 papers), Cancer-related Molecular Pathways (2 papers), Kruppel-like factors research (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Protease and Inhibitor Mechanisms (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). The work is most often cited by research in Microbiology (25 citations), Oncology (326 citations), Endocrinology, Diabetes and Metabolism (147 citations), Orthopedics and Sports Medicine (48 citations) and Cell Biology (98 citations). Erik Springer has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Helmut E. Gabbert, Claus Dieter Gerharz, Michael Wenzel, Csaba Mahotka, Achim Weber, Arno Schad, C. James Kirkpatrick, Martin Kunkel, Thomas J. Musholt and Torsten Hansen. Their work appears in journals such as Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, European Journal of Surgical Oncology, The American Journal of Gastroenterology, ORL and Journal of Clinical Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact